biopharma regulatory affairs

Announcing new Director of BioPharma Regulatory Affairs - Julie Matison

August 7, 2025
biopharma regulatory affairs

We are excited to announce that Julie Matison has joined GLOBAL as our new Director of BioPharma Regulatory Affairs.

Julie brings more than 21 years of experience in the pharmaceutical industry, with a strong background in manufacturing, validation, and quality. Her expertise spans nonclinical, CMC, and clinical regulatory areas, where she has successfully led complex projects and provided strategic guidance to clients.

In addition to her technical and leadership skills, Julie holds a Bachelor’s degree in Chemical Engineering and a Master’s degree in Mechanical Engineering, and recently earned the RAC-Drugs certification through RAPS, underscoring her commitment to regulatory excellence.

We are delighted to welcome Julie to the GLOBAL team and look forward to the expertise and leadership she will bring.!

Read More Recent News from GLOBAL

April 2, 2024

GLOBAL Regulatory Writing & Consulting - New CEO

May 2, 2024

GLOBAL Announces Sarra de Valence as Vice President of Medical Devices and Operations

September 4, 2024

GLOBAL RWC Leads Tech Innovation at RAPS Convergence!

Let’s Get Started

GLOBAL provides trusted regulatory consulting , writing, and technology solutions to help manufacturers bring products to patients at a life saving pace. We’ll be with you every step of the way.

BOOK a CONSULTATION